申请人:MILLER Scott
公开号:US20120270878A1
公开(公告)日:2012-10-25
This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases and proteolytic enzyme mediated diseases, and pharmaceutical compositions for use in such therapy.
本发明涉及使用一组芳基脲类化合物治疗细胞因子介导的疾病和蛋白酶酶介导的疾病,以及用于该治疗的药物组合物。